Characteristic features of CHAI and LATAIE disease
Patient . | Mutation . | HGG . | AIHA . | ITP . | LAD . | Splenomegaly . | ILD . | Enteropathy . | Brain lesions . | Reference . |
---|---|---|---|---|---|---|---|---|---|---|
CHAI | ||||||||||
P1 | p.R51* | + | + | + | 4 | |||||
P2 | p.R51* | + | + | + | + | + | 4 | |||
P3 | p.L28Ffs*44 | + | + | + | + | + | + | + | 4 | |
P4 | Splice site, c.458-1G>C | + | + | + | + | + | 4 | |||
P5 | Splice site, c.567+5G>C | + | + | + | + | + | + | 4 | ||
P6 | Splice site, c.567+5G>C | + | + | + | + | + | + | 4 | ||
P7 | p.C35* | + | + | + | 5 | |||||
P8 | p.C35* | + | + | + | 5 | |||||
P9 | p.C35* | + | + | + | + | 5 | ||||
P10 | p.C35* | + | + | + | + | 5 | ||||
P11 | p.C35* | + | + | + | + | + | + | 5 | ||
P12 | Splice site, c.110+1G>T | ND | ND | + | 5 | |||||
P13 | Splice site, c.110+1G>T | ND | ND | ND | ND | + | 5 | |||
P14 | Splice site, c.110+1G>T | + | + | 5 | ||||||
P15 | Splice site, c.110+1G>T | + | + | 5 | ||||||
P16 | p.R70W | + | + | + | + | + | + | 5 | ||
P17 | p.R70W | + | ND | 5 | ||||||
P18 | p.T124P | + | + | + | + | + | 5 | |||
P19 | p.R75W | + | + | + | + | + | + | + | 5 | |
P20 | Start codon, c.2T>C | + | + | + | + | 5 | ||||
P21 | p.L28Sfs*40 | + | + | 16 | ||||||
LATAIE | ||||||||||
P1 | p.I2657S | + | + | + | + | 6 | ||||
P2 | p.I2657S | + | + | 6 | ||||||
P3 | p.R1683* | + | + | + | + | + | + | + | 6 | |
P4 | p.E59* | + | + | + | + | + | 6 | |||
P5 | Exon 1-2 deletion | + | + | 6 | ||||||
P6 | p.E2219Dfs*3 | + | + | + | 7 | |||||
P7 | p.E2219Dfs*3 | + | 7 | |||||||
P8 | p.E2219Dfs*3 | + | + | 7 | ||||||
P9 | p.E2219Dfs*3 | + | + | + | + | 7 | ||||
P10 | p.E2219Dfs*3 | + | + | 7 | ||||||
P11 | Exons 1-30 deletion | + | + | + | + | + | + | 8 | ||
P12 | p.T2388Pfs*7 | + | + | + | + | 10 | ||||
P13 | p.T2388Pfs*7 | + | + | + | 10 | |||||
P14 | p.Q678* | + | + | 9 | ||||||
P15 | p.C289Cfs*3 | + | + | + | + | + | 9 | |||
P16 | p.C289Cfs*3 | + | + | + | + | 9 | ||||
P17 | p.I2657S | + | + | + | + | + | 11 | |||
P18 | p.S2713fs | + | + | + | + | 11 | ||||
P19 | p.S2713fs | + | + | + | + | 11 | ||||
P20 | p.R1445Q | + | + | + | + | + | + | + | 12 | |
P21 | p.R1445Q | + | + | + | + | + | 12 | |||
P22 | p.K175*; T1587fs | + | + | + | + | + | + | 12 | ||
P23 | p.R1445* | + | + | + | + | + | 12 | |||
P24 | p.S1233F; Q2506* | + | + | + | + | 12 | ||||
P25 | p.V2249F; L1834P | + | + | + | + | + | + | + | 12 | |
P26 | p.R655* | + | + | + | + | + | + | + | 12 | |
P27 | p.D248G; c.8502-1G>C | + | + | + | 12 | |||||
P28 | p.D1329fs | + | 12 | |||||||
Frequency (%) | ||||||||||
In CHAI | 75 | 38 | 43 | 40 | 53 | 63 | 81 | 20 | ||
In LATAIE | 57 | 54 | 64 | 50 | 57 | 43 | 71 | 11 |
Patient . | Mutation . | HGG . | AIHA . | ITP . | LAD . | Splenomegaly . | ILD . | Enteropathy . | Brain lesions . | Reference . |
---|---|---|---|---|---|---|---|---|---|---|
CHAI | ||||||||||
P1 | p.R51* | + | + | + | 4 | |||||
P2 | p.R51* | + | + | + | + | + | 4 | |||
P3 | p.L28Ffs*44 | + | + | + | + | + | + | + | 4 | |
P4 | Splice site, c.458-1G>C | + | + | + | + | + | 4 | |||
P5 | Splice site, c.567+5G>C | + | + | + | + | + | + | 4 | ||
P6 | Splice site, c.567+5G>C | + | + | + | + | + | + | 4 | ||
P7 | p.C35* | + | + | + | 5 | |||||
P8 | p.C35* | + | + | + | 5 | |||||
P9 | p.C35* | + | + | + | + | 5 | ||||
P10 | p.C35* | + | + | + | + | 5 | ||||
P11 | p.C35* | + | + | + | + | + | + | 5 | ||
P12 | Splice site, c.110+1G>T | ND | ND | + | 5 | |||||
P13 | Splice site, c.110+1G>T | ND | ND | ND | ND | + | 5 | |||
P14 | Splice site, c.110+1G>T | + | + | 5 | ||||||
P15 | Splice site, c.110+1G>T | + | + | 5 | ||||||
P16 | p.R70W | + | + | + | + | + | + | 5 | ||
P17 | p.R70W | + | ND | 5 | ||||||
P18 | p.T124P | + | + | + | + | + | 5 | |||
P19 | p.R75W | + | + | + | + | + | + | + | 5 | |
P20 | Start codon, c.2T>C | + | + | + | + | 5 | ||||
P21 | p.L28Sfs*40 | + | + | 16 | ||||||
LATAIE | ||||||||||
P1 | p.I2657S | + | + | + | + | 6 | ||||
P2 | p.I2657S | + | + | 6 | ||||||
P3 | p.R1683* | + | + | + | + | + | + | + | 6 | |
P4 | p.E59* | + | + | + | + | + | 6 | |||
P5 | Exon 1-2 deletion | + | + | 6 | ||||||
P6 | p.E2219Dfs*3 | + | + | + | 7 | |||||
P7 | p.E2219Dfs*3 | + | 7 | |||||||
P8 | p.E2219Dfs*3 | + | + | 7 | ||||||
P9 | p.E2219Dfs*3 | + | + | + | + | 7 | ||||
P10 | p.E2219Dfs*3 | + | + | 7 | ||||||
P11 | Exons 1-30 deletion | + | + | + | + | + | + | 8 | ||
P12 | p.T2388Pfs*7 | + | + | + | + | 10 | ||||
P13 | p.T2388Pfs*7 | + | + | + | 10 | |||||
P14 | p.Q678* | + | + | 9 | ||||||
P15 | p.C289Cfs*3 | + | + | + | + | + | 9 | |||
P16 | p.C289Cfs*3 | + | + | + | + | 9 | ||||
P17 | p.I2657S | + | + | + | + | + | 11 | |||
P18 | p.S2713fs | + | + | + | + | 11 | ||||
P19 | p.S2713fs | + | + | + | + | 11 | ||||
P20 | p.R1445Q | + | + | + | + | + | + | + | 12 | |
P21 | p.R1445Q | + | + | + | + | + | 12 | |||
P22 | p.K175*; T1587fs | + | + | + | + | + | + | 12 | ||
P23 | p.R1445* | + | + | + | + | + | 12 | |||
P24 | p.S1233F; Q2506* | + | + | + | + | 12 | ||||
P25 | p.V2249F; L1834P | + | + | + | + | + | + | + | 12 | |
P26 | p.R655* | + | + | + | + | + | + | + | 12 | |
P27 | p.D248G; c.8502-1G>C | + | + | + | 12 | |||||
P28 | p.D1329fs | + | 12 | |||||||
Frequency (%) | ||||||||||
In CHAI | 75 | 38 | 43 | 40 | 53 | 63 | 81 | 20 | ||
In LATAIE | 57 | 54 | 64 | 50 | 57 | 43 | 71 | 11 |
CTLA4 mutations in CHAI patients are heterozygous. LRBA mutations in LATAIE patients are homozygous or compound heterozygous.
AIHA, autoimmune hemolytic anemia; HGG, hypogammaglobulinemia; ILD, interstitial lung disease; ITP, immune thrombocytopenia; LAD, lymphadenopathy; ND, not determined; P, patient.